Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Asset Utilization Ratio of 0.01 for Q3 2025, down 53.26% year-over-year from 0.01 in Q3 2024, and down 52.44% quarter-over-quarter from 0.01 in Q2 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.01 for Q3 2025.
- In Q3 2025, Asset Utilization Ratio fell 53.26% year-over-year to 0.01; the TTM figure through Sep 2025 stood at 0.01 (down 53.26% YoY), while the FY2024 annual figure was 0.02, up 4.66% from the prior year.
- Asset Utilization Ratio for Q3 2025 stood at 0.01, down from 0.01 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.05 in Q2 2023, with the low at 0.01 in Q3 2025.
- The 4-year median for Asset Utilization Ratio is 0.02 (2023), against an average of 0.02.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio jumped 283.94% in 2023, then tumbled 77.09% in 2024.
- Dianthus Therapeutics' Asset Utilization Ratio stood at 0.02 in 2022, then retreated by 19.3% to 0.02 in 2023, then grew by 11.71% to 0.02 in 2024, then tumbled by 59.73% to 0.01 in 2025.
- Business Quant data shows DNTH's Asset Utilization Ratio at 0.01 in Q3 2025, 0.01 in Q2 2025, and 0.02 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.01 |